3 results
Approved WMOPending
This trial will compare the effectiveness and possible adverse effects of five common wound dressing materials to treat donor sites of split skin grafts.
Approved WMOCompleted
To assess PK of MPhs and MP.
Approved WMORecruiting
Primary(Part I and Part II):- To determine the maximum tolerated dose (MTD) and/or recommended Phase 2 dose (RP2D) in the QW and/or Q3W regimens of RO7122290 in combination with cibisatamab after pretreatment with obinutuzumab- To characterize theā¦